Sagimet Biosciences Inc.
SGMT
$7.11
-$0.24-3.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -103.01% | -104.58% | -63.46% | -39.36% | -4.34% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.33% | -7.48% | -17.85% | -9.02% | 69.55% |
| Change in Net Operating Assets | -87.84% | 1,595.28% | -7.16% | -206.70% | 221.99% |
| Cash from Operations | -137.81% | -121.77% | -78.55% | -59.49% | 13.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.65% | -1,503.93% | -590.33% | -342.20% | -320.43% |
| Cash from Investing | 100.65% | -1,503.93% | -590.33% | -342.20% | -320.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | 18.04% | 26.94% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 99.39% | 70.30% | -8,196.36% | -219.44% |
| Cash from Financing | -100.00% | -100.01% | 21.65% | 21.72% | 17,541.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.25% | -168.15% | -99.07% | -124.92% | 451.49% |